(Date:11/5/2009)...Colo., Nov. 5 The endangered black...estern U.S. This rare carnivore feeds on prairie ...lague and often entire population die-offs in town...S) has implemented a ferret breeding program and h...eir formerly native habitat. Unfortunately, plagu...
(Date:11/5/2009)...ov. 5 Imagenetix, Inc. (...lliam Spencer, President and CEO of Imagenetix, wi...nual LD MICRO Conference on Thursday, December 3rd...s. ,, About LD MICRO ,, LD MICRO is a by-inv...ng undervalued companies in the micro-cap space. S...
(Date:11/5/2009)...all on Thursday, November 5, 2009 at 4:30 p.m. Eas.../PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals...XI ) today reported unaudited financial results fo...r 30, 2009 and reviewed the Company,s highlights f...consolidated results reflect the operations of Onc...
(Date:11/5/2009)...Y., Nov. 5 BioSpecifics ...utical company developing first-in-class collagena...esults for the third quarter ended September 30, 2...ember of this year, the FDA,s Arthritis Advisory C...0, the approval of XIAFLEX(TM) for the treatment o...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5...nounced new data,demonstrating that the investigat...e Vimpat(TM), administered as oral, adjunctive the...es and was generally,well-tolerated in patients wi...5.5 years. The results of the two Phase II trials ...t the 61st annual meeting of the American,Epilepsy...
...ility & Diet" (p. 54). The latest chapter,of Newsw...st research on,how foods impact the odds of gettin.... Chavarro, M.D., Walter C. Willett, M.D., and Pat...tility Diet," break down the,roles diet, exercise ... on,their surprising findings. Some of the keys to...
...RSBURG, Md., Nov. 30 Binex,(KOSDAQ: 053030) and M...sored Research Agreement to evaluate MaxCyte,s GMP...ed-system manufacturing of Binex,s,cell-based canc...h studies,the agreement provides Binex an option t...mmercial use in Korea. Financial terms were not di...
Other Biology Technology:UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients 2UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients 3UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients 4NEWSWEEK: Media Lead Sheet/December 10, 2007 Issue (on newsstands Monday, December 3). 2NEWSWEEK: Media Lead Sheet/December 10, 2007 Issue (on newsstands Monday, December 3). 3NEWSWEEK: Media Lead Sheet/December 10, 2007 Issue (on newsstands Monday, December 3). 4NEWSWEEK: Media Lead Sheet/December 10, 2007 Issue (on newsstands Monday, December 3). 5Binex and MaxCyte Collaborate on Cancer Immunotherapy Research 2Rat Anti-Mouse Activin RIB / ALK-4 Monoclonal Antibody, Unconjugated, Clone 207304 from R&D Systems
Normal Human Serum from 3H Biomedical AB
...ns oligos for SYBR Green, TaqMan, LNA spiked TaqMa...says. Highly specific primers are designed by avoi...preting BLAST search results. Primer efficiency is...s identified by connecting to the Mfold server. Be...
Agar (BACTERIOLOGICAL GRADE) from GE Healthcare, formerly Amersham Biosciences
Biology Products: